相关实验视频

Updated: Jun 19, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

授权有效的生物标志物驱动精确瘤学:呼吁采取行动

Mark Lawler¹, Peter Keeling², Olga Kholmanskikh³

¹Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, BT9 7AE, UK; Cancer Drug Development Forum, Clos Chapelle-aux-Champs 30, 1200 Brussels, Belgium.

European journal of cancer (Oxford, England : 1990)

|July 25, 2024

概括

精密瘤学利用生物标志物来更好地诊断,预后和治疗癌症. 将基因组测试整合到日常护理中对于有效,经济高效的癌症治疗和改善患者治疗结果至关重要.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
生物标志物发现发现

背景情况:

精确瘤学依赖于生物标志物进行癌症诊断,预后和治疗预测.
基因组测试的进步尚未完全整合到临床实践中,阻碍了最佳的患者护理.
生物标志物测试可用性和实施的延迟限制了获得拯救生命的治疗方法的机会.

研究的目的:

突出生物标志物在精密瘤学中的关键作用.
识别阻碍生物标志物测试的常规采用障碍.
倡导将精确基因组测试整合到标准瘤治疗中.

主要方法:

审查生物标志物测试实施当前的挑战.
分析阻碍诊断途径的因素.
综合证据支持精密瘤学的成本效益.

主要成果:

基因组测试在临床实践中未得到充分利用,导致错过了治疗机会.
障碍包括成本,报销问题,有限的访问,监管障碍和测试验证需求.
精确瘤学可以具有成本效益,即使在资源有限的环境中.

结论:

生物标志物测试对于个性化癌症护理和药物开发至关重要.
精确基因组测试的常规整合是必要的,以改善患者的治疗结果.
需要提出建议和呼吁采取行动,以将生物标志物信息化瘤学纳入主流.

关键词:

生物标志物生物标志物综合性基因组分析分析成本效益性成本效益性在体外诊断在体外诊断.精确瘤学是一门精确的专业.

更多相关视频

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...